{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:37:52Z","timestamp":1791589072731,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UVA2014-7245"],"award-info":[{"award-number":["UVA2014-7245"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UVA2014-10150"],"award-info":[{"award-number":["UVA2014-10150"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021821","name":"Oncode Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Colorectal cancer (CRC) can be divided into four consensus molecular subtypes (CMS), each with distinct biological features. CMS4 is associated with epithelial-mesenchymal transition and stromal infiltration (Guinney et al., Nat Med 21:1350\u20136, 2015; Linnekamp et al., Cell Death Differ 25:616\u201333, 2018), whereas clinically it is characterized by lower responses to adjuvant therapy, higher incidence of metastatic spreading and hence dismal prognosis (Buikhuisen et al., Oncogenesis 9:66, 2020).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To understand the biology of the mesenchymal subtype and unveil specific vulnerabilities, a large CRISPR-Cas9 drop-out screen was performed on 14 subtyped CRC cell lines to uncover essential kinases in all CMSs. Dependency of CMS4 cells on p21-activated kinase 2 (PAK2) was validated in independent 2D and 3D in vitro cultures and in vivo models assessing primary and metastatic outgrowth in liver and peritoneum. TIRF microscopy was used to uncover actin cytoskeleton dynamics and focal adhesion localization upon PAK2 loss. Subsequent functional assays were performed to determine altered growth and invasion patterns.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PAK2 was identified as a key kinase uniquely required for growth of the mesenchymal subtype CMS4, both in vitro and in vivo. PAK2 plays an important role in cellular attachment and cytoskeletal rearrangements (Coniglio et al., Mol Cell Biol 28:4162\u201372, 2008; Grebenova et al., Sci Rep 9:17171, 2019). In agreement, deletion or inhibition of PAK2 impaired actin cytoskeleton dynamics in CMS4 cells and, as a consequence, significantly reduced invasive capacity, while it was dispensable for CMS2 cells. Clinical relevance of these findings was supported by the observation that deletion of PAK2 from CMS4 cells prevented metastatic spreading in vivo. Moreover, growth in a model for peritoneal metastasis was hampered when CMS4 tumor cells were deficient for PAK2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our data reveal a unique dependency of mesenchymal CRC and provide a rationale for PAK2 inhibition to target this aggressive subgroup of colorectal cancer.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13046-023-02600-9","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T05:02:40Z","timestamp":1677819760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer"],"prefix":"10.1186","volume":"42","author":[{"given":"Joyce Y.","family":"Buikhuisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Gomez Barila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia J. E.","family":"Suijkerbuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cor","family":"Lieftink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"di Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Krotenberg Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Uceda Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiaan J.","family":"Lenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisanne E.","family":"Nijman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezo","family":"Torang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Longobardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan H.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Stassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick L.","family":"Beijersbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacco","family":"van Rheenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Huveneers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Paul","family":"Medema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"2600_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","volume":"6","author":"ER Fearon","year":"2011","unstructured":"Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6:479\u2013507.","journal-title":"Annu Rev Pathol"},{"issue":"7407","key":"2600_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"N. CGA.","year":"2012","unstructured":"N. CGA. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330\u20137.","journal-title":"Nature."},{"issue":"4","key":"2600_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrclinonc.2016.171","volume":"14","author":"CJA Punt","year":"2017","unstructured":"Punt CJA, Koopman M, Vermeulen L. From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat Rev Clin Oncol. 2017;14(4):235\u201346.","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"2600_CR4","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350\u20136.","journal-title":"Nat Med"},{"issue":"4","key":"2600_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ng.3225","volume":"47","author":"A Calon","year":"2015","unstructured":"Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet. 2015;47(4):320\u20139.","journal-title":"Nat Genet"},{"issue":"4","key":"2600_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ng.3224","volume":"47","author":"C Isella","year":"2015","unstructured":"Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, et al. Stromal contribution to the colorectal cancer transcriptome. Nat Genet. 2015;47(4):312\u20139.","journal-title":"Nat Genet"},{"issue":"7","key":"2600_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41389-020-00250-6","volume":"9","author":"JY Buikhuisen","year":"2020","unstructured":"Buikhuisen JY, Torang A, Medema JP. Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges. Oncogenesis. 2020;9(7):66.","journal-title":"Oncogenesis."},{"issue":"3","key":"2600_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41418-017-0011-5","volume":"25","author":"JF Linnekamp","year":"2018","unstructured":"Linnekamp JF, Hooff SRV, Prasetyanti PR, Kandimalla R, Buikhuisen JY, Fessler E, et al. Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models. Cell Death Differ. 2018;25(3):616\u201333.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2600_CR9","doi-asserted-by":"publisher","first-page":"16618","DOI":"10.1038\/s41598-017-16747-x","volume":"7","author":"PW Eide","year":"2017","unstructured":"Eide PW, Bruun J, Lothe RA, Sveen A. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Sci Rep. 2017;7(1):16618.","journal-title":"Sci Rep"},{"issue":"4","key":"2600_CR10","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1158\/1078-0432.CCR-17-1234","volume":"24","author":"A Sveen","year":"2018","unstructured":"Sveen A, Bruun J, Eide PW, Eilertsen IA, Ramirez L, Murumagi A, et al. Colorectal cancer consensus molecular subtypes translated to preclinical models uncover potentially targetable cancer cell dependencies. Clin Cancer Res. 2018;24(4):794\u2013806.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2600_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s41374-020-0448-x","volume":"100","author":"VP Bastiaenen","year":"2020","unstructured":"Bastiaenen VP, Klaver CEL, van der Heijden MCS, Nijman LE, Lecca MC, Tanis PJ, et al. A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity. Lab Invest. 2020;100(11):1465\u201374.","journal-title":"Lab Invest"},{"issue":"3","key":"2600_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccell.2019.08.003","volume":"36","author":"R Jackstadt","year":"2019","unstructured":"Jackstadt R, van Hooff SR, Leach JD, Cortes-Lavaud X, Lohuis JO, Ridgway RA, et al. Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis. Cancer Cell. 2019;36(3):319\u201336 e7.","journal-title":"Cancer Cell"},{"issue":"1","key":"2600_CR13","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1038\/s41467-022-32198-z","volume":"13","author":"KJ Lenos","year":"2022","unstructured":"Lenos KJ, Bach S, Ferreira Moreno L, Ten Hoorn S, Sluiter NR, Bootsma S, et al. Molecular characterization of colorectal cancer related peritoneal metastatic disease. Nat Commun. 2022;13(1):4443.","journal-title":"Nat Commun"},{"issue":"4","key":"2600_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161(4):933\u201345.","journal-title":"Cell."},{"issue":"1","key":"2600_CR15","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1038\/s41598-017-07660-4","volume":"7","author":"M Alieva","year":"2017","unstructured":"Alieva M, Margarido AS, Wieles T, Abels ER, Colak B, Boquetale C, et al. Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior. Sci Rep. 2017;7(1):7529.","journal-title":"Sci Rep"},{"issue":"12","key":"2600_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"12","key":"2600_CR17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 2014;15(12):554.","journal-title":"Genome Biol"},{"issue":"3","key":"2600_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307\u201315.","journal-title":"Bioinformatics."},{"issue":"1","key":"2600_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327.","journal-title":"Biostatistics."},{"issue":"11","key":"2600_CR20","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281\u2013308.","journal-title":"Nat Protoc"},{"issue":"22","key":"2600_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42(22):e168.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"2600_CR22","doi-asserted-by":"publisher","first-page":"D792","DOI":"10.1093\/nar\/gkp1005","volume":"38","author":"A Spandidos","year":"2010","unstructured":"Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010;38(Database issue):D792\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2600_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ab.2003.10.047","volume":"326","author":"CL Ladner","year":"2004","unstructured":"Ladner CL, Yang J, Turner RJ, Edwards RA. Visible fluorescent detection of proteins in polyacrylamide gels without staining. Anal Biochem. 2004;326(1):13\u201320.","journal-title":"Anal Biochem"},{"key":"2600_CR24","doi-asserted-by":"crossref","unstructured":"Buikhuisen JY, Gomez Barila PM, Torang A, Dekker D, de Jong JH, Cameron K, et al. AKT3 expression in mesenchymal colorectal cancer cells drives growth and is associated with epithelial-mesenchymal transition. Cancers (Basel). 2021;13(4):801","DOI":"10.3390\/cancers13040801"},{"issue":"5","key":"2600_CR25","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315\u20139.","journal-title":"Nat Protoc"},{"key":"2600_CR26","doi-asserted-by":"crossref","unstructured":"van der Stoel M, Schimmel L, Nawaz K, van Stalborch AM, de Haan A, Klaus-Bergmann A, et al. DLC1 is a direct target of activated YAP\/TAZ that drives collective migration and sprouting angiogenesis. J Cell Sci. 2020;133(3):jcs239947.","DOI":"10.1242\/jcs.239947"},{"issue":"12","key":"2600_CR27","doi-asserted-by":"publisher","first-page":"E2357","DOI":"10.1073\/pnas.1701219114","volume":"114","author":"A Fumagalli","year":"2017","unstructured":"Fumagalli A, Drost J, Suijkerbuijk SJ, van Boxtel R, de Ligt J, Offerhaus GJ, et al. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc Natl Acad Sci U S A. 2017;114(12):E2357\u2013E64.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2600_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrc3645","volume":"14","author":"M Radu","year":"2014","unstructured":"Radu M, Semenova G, Kosoff R, Chernoff J. PAK signalling during the development and progression of cancer. Nat Rev Cancer. 2014;14(1):13\u201325.","journal-title":"Nat Rev Cancer"},{"key":"2600_CR29","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.1038\/ncomms8437","volume":"6","author":"HJ Whalley","year":"2015","unstructured":"Whalley HJ, Porter AP, Diamantopoulou Z, White GR, Castaneda-Saucedo E, Malliri A. Cdk1 phosphorylates the Rac activator Tiam1 to activate centrosomal Pak and promote mitotic spindle formation. Nat Commun. 2015;6:7437.","journal-title":"Nat Commun"},{"issue":"5318","key":"2600_CR30","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1126\/science.276.5318.1571","volume":"276","author":"T Rudel","year":"1997","unstructured":"Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science. 1997;276(5318):1571\u20134.","journal-title":"Science."},{"issue":"Suppl 6","key":"2600_CR31","first-page":"S3","volume":"5","author":"SB Horwitz","year":"1994","unstructured":"Horwitz SB. Taxol (paclitaxel): mechanisms of action. Ann Oncol. 1994;5(Suppl 6):S3\u20136.","journal-title":"Ann Oncol"},{"issue":"1","key":"2600_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.str.2016.11.001","volume":"25","author":"SJ Eron","year":"2017","unstructured":"Eron SJ, Raghupathi K, Hardy JA. Dual site phosphorylation of Caspase-7 by PAK2 blocks apoptotic activity by two distinct mechanisms. Structure. 2017;25(1):27\u201339.","journal-title":"Structure."},{"issue":"3","key":"2600_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1593\/neo.81446","volume":"11","author":"JW Marlin","year":"2009","unstructured":"Marlin JW, Eaton A, Montano GT, Chang YW, Jakobi R. Elevated p21-activated kinase 2 activity results in anchorage-independent growth and resistance to anticancer drug-induced cell death. Neoplasia. 2009;11(3):286\u201397.","journal-title":"Neoplasia."},{"issue":"20","key":"2600_CR34","doi-asserted-by":"publisher","first-page":"16624","DOI":"10.1074\/jbc.M007753200","volume":"276","author":"R Jakobi","year":"2001","unstructured":"Jakobi R, Moertl E, Koeppel MA. p21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J Biol Chem. 2001;276(20):16624\u201334.","journal-title":"J Biol Chem"},{"issue":"D1","key":"2600_CR35","doi-asserted-by":"publisher","first-page":"D776","DOI":"10.1093\/nar\/gkx993","volume":"46","author":"WF Lenoir","year":"2018","unstructured":"Lenoir WF, Lim TL, Hart T. PICKLES: the database of pooled in-vitro CRISPR knockout library essentiality screens. Nucleic Acids Res. 2018;46(D1):D776\u2013D80.","journal-title":"Nucleic Acids Res"},{"key":"2600_CR36","doi-asserted-by":"crossref","unstructured":"Kim E, Dede M, Lenoir WF, Wang G, Srinivasan S, Colic M, et al. A network of human functional gene interactions from knockout fitness screens in cancer cells. Life Sci Alliance. 2019;2(2):e201800278.","DOI":"10.26508\/lsa.201800278"},{"issue":"16","key":"2600_CR37","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1182\/blood-2016-01-693572","volume":"127","author":"PN Reddy","year":"2016","unstructured":"Reddy PN, Radu M, Xu K, Wood J, Harris CE, Chernoff J, et al. p21-activated kinase 2 regulates HSPC cytoskeleton, migration, and homing via CDC42 activation and interaction with beta-Pix. Blood. 2016;127(16):1967\u201375.","journal-title":"Blood."},{"issue":"14","key":"2600_CR38","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1242\/jcs.196147","volume":"130","author":"S Hiroyasu","year":"2017","unstructured":"Hiroyasu S, Stimac GP, Hopkinson SB, Jones JCR. Loss of beta-PIX inhibits focal adhesion disassembly and promotes keratinocyte motility via myosin light chain activation. J Cell Sci. 2017;130(14):2329\u201343.","journal-title":"J Cell Sci"},{"issue":"Pt 3","key":"2600_CR39","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1242\/jcs.031146","volume":"122","author":"J van Rheenen","year":"2009","unstructured":"van Rheenen J, Condeelis J, Glogauer M. A common cofilin activity cycle in invasive tumor cells and inflammatory cells. J Cell Sci. 2009;122(Pt 3):305\u201311.","journal-title":"J Cell Sci"},{"key":"2600_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ceb.2015.06.007","volume":"36","author":"G Jacquemet","year":"2015","unstructured":"Jacquemet G, Hamidi H, Ivaska J. Filopodia in cell adhesion, 3D migration and cancer cell invasion. Curr Opin Cell Biol. 2015;36:23\u201331.","journal-title":"Curr Opin Cell Biol"},{"issue":"8","key":"2600_CR41","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41416-021-01477-9","volume":"125","author":"S Ten Hoorn","year":"2021","unstructured":"Ten Hoorn S, Sommeijer DW, Elliott F, Fisher D, de Back TR, Trinh A, et al. Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone. Br J Cancer. 2021;125(8):1080\u20138.","journal-title":"Br J Cancer"},{"issue":"1","key":"2600_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ydbio.2003.06.003","volume":"265","author":"M Raftopoulou","year":"2004","unstructured":"Raftopoulou M, Hall A. Cell migration: rho GTPases lead the way. Dev Biol. 2004;265(1):23\u201332.","journal-title":"Dev Biol"},{"issue":"2","key":"2600_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1083\/jcb.201612069","volume":"217","author":"CD Lawson","year":"2018","unstructured":"Lawson CD, Ridley AJ. Rho GTPase signaling complexes in cell migration and invasion. J Cell Biol. 2018;217(2):447\u201357.","journal-title":"J Cell Biol"},{"issue":"12","key":"2600_CR44","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1128\/MCB.01532-07","volume":"28","author":"SJ Coniglio","year":"2008","unstructured":"Coniglio SJ, Zavarella S, Symons MH. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. Mol Cell Biol. 2008;28(12):4162\u201372.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2600_CR45","doi-asserted-by":"publisher","first-page":"17171","DOI":"10.1038\/s41598-019-53665-6","volume":"9","author":"D Grebenova","year":"2019","unstructured":"Grebenova D, Holoubek A, Roselova P, Obr A, Brodska B, Kuzelova K. PAK1, PAK1Delta15, and PAK2: similarities, differences and mutual interactions. Sci Rep. 2019;9(1):17171.","journal-title":"Sci Rep"},{"issue":"7","key":"2600_CR46","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41556-019-0337-y","volume":"21","author":"J Diring","year":"2019","unstructured":"Diring J, Mouilleron S, McDonald NQ, Treisman R. RPEL-family rhoGAPs link Rac\/Cdc42 GTP loading to G-actin availability. Nat Cell Biol. 2019;21(7):845\u201355.","journal-title":"Nat Cell Biol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02600-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-023-02600-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02600-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T17:17:42Z","timestamp":1729012662000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-023-02600-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2600"],"URL":"https:\/\/doi.org\/10.1186\/s13046-023-02600-9","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}